생명과학회지 (Journal of Life Science)

  • 제22권1호
  • /
  • Pages.41-48
  • /
  • 2012
  • /
  • 1225-9918(pISSN)
  • /
  • 2287-3406(eISSN)
한국생명과학회 (Korean Society of Life Science)
권호 표지
DOI QR코드

DOI QR Code

봉독의 HIF-1α 발현감소를 통한 혈관신생 억제효과

Bee Venom Inhibits Angiogenesis by Decreasing HIF-1α Expression in HCT116 Cells

  • 신재문 (대구가톨릭대학교 의용생체공학연구소) ;
  • 정윤정 (대구가톨릭대학교 의용생체공학연구소) ;
  • 박관규 (대구가톨릭대학교 의용생체공학연구소) ;
  • 최정윤 (대구가톨릭대학교 의용생체공학연구소) ;
  • 한상미 (농촌진흥청 국립농업과학원) ;
  • 이광길 (농촌진흥청 국립농업과학원) ;
  • 여주홍 (농촌진흥청 국립농업과학원) ;
  • 정일경 (대구가톨릭대학교 자연대학 생명공학과) ;
  • 장영채 (대구가톨릭대학교 의용생체공학연구소)
  • Shin, Jae-Moon (Research Institute of Biomedical Engineering, Catholic University of Daegu School of Medicine) ;
  • Jeong, Yun-Jeong (Research Institute of Biomedical Engineering, Catholic University of Daegu School of Medicine) ;
  • Park, Kwan-Kyu (Research Institute of Biomedical Engineering, Catholic University of Daegu School of Medicine) ;
  • Choe, Jung-Yoon (Research Institute of Biomedical Engineering, Catholic University of Daegu School of Medicine) ;
  • Han, Sang-Mi (Department of Agricultural Biology, National Institute of Agricultural Science and Technology) ;
  • Lee, Kwang-Gill (Department of Agricultural Biology, National Institute of Agricultural Science and Technology) ;
  • Yeo, Joo-Hong (Department of Agricultural Biology, National Institute of Agricultural Science and Technology) ;
  • Chung, Il-Kyung (Department of Biotechnology, Catholic University of Daegu) ;
  • Chang, Young-Chae (Research Institute of Biomedical Engineering, Catholic University of Daegu School of Medicine)
  • 투고 : 2011.10.10
  • 심사 : 2012.01.09
  • 발행 : 2012.01.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

봉독은 동양의학에서 관절염, 류마티즘 및 각종 암을 포함하여 다양한 질병을 치료하기 위하여 이용되었다. 최근 봉독의 신생혈관 억제효과에 대한 연구가 보고되었으나 정확한 분자메커니즘에 대해서는 보고가 미흡하다. 따라서, 본 연구는 봉독이 인간결장암세포인 HCT116세포에서 신생혈관생성과 종양진행에 중요한 역할을 하는 HIF-$1{\alpha}$와 VEGF 발현 억제효과를 조사하였다. 그 결과 봉독은 $CoCl_2$로 유도한 저산소 상태에서 VEGF와, HIF-$1{\alpha}$의 발현을 감소시키며 HIF-$1{\alpha}$의 promoter 영역인 HRE 활성을 억제하였다. 이러한 봉독의 HIF-$1{\alpha}$ 발현억제효과는 ERK1/2의 인산화 조절을 통한 것이며, 봉독은 p38, JNK, AKT의 인산화에는 영향을 끼치지 않았다. 또한 봉독의 효과를 나타내는 단일물질 탐색을 위해 봉독의 생리활성 물질로 알려진 아파민과 멜리틴을 조사한 결과, HIF-$1{\alpha}$와 VEGF 억제효과는 아파민에 기인하는 것이라고 예상 할 수 있었다. 이와 같은 결과를 통하여 본 연구에서는 봉독의 혈관신생 억제에 대한 새로운 신호전달기전 및 인간 결장암세포 전이 억제제로서의 잠재성을 확인하였다.

Bee venom (BV) has been used in medicine to treat a variety of diseases including arthritis, rheumatism, and various cancers. Recent reports indicate that BV has anti-angiogenic effects, but the precise molecular mechanism underlying the effects of BV against colorectal cancer remains to be elucidated. We examined the effects of BV and its major components (melittin and apamin) on tumor angiogenesis and found that BV significantly decreased protein levels of hypoxia-inducible factor-$1{\alpha}$ (HIF-$1{\alpha}$), an important factor involved in angiogenesis and tumor progression, in human colorectal carcinoma HCT116 cells. BV also suppressed the transcription of HIF-$1{\alpha}$ under hypoxia, leading to a decrease in the expression of vascular endothelial growth factor (VEGF), a major target gene of HIF-$1{\alpha}$. We also found that these effects were mainly elicited by apamin, but not melittin. BV specifically inhibited the phosphorylation of ERK1/2 without changing the total levels of this protein, but had no effect on kinases of p38/JNK and AKT. Our results suggest that BV may inhibit human colorectal cancer progression and angiogenesis by inhibiting HIF-$1{\alpha}$ and VEGF expression, thereby providing a novel potential mechanism for the anticancer action of BV.

키워드

참고문헌

  1. Brahmachari, H. D. and S. Joseph. 1973. Cobalt compounds for the control of hypoxic stress. Aerosp Med. 44, 636-638.
  2. Bremnes, R. M., C. Camps, and R. Sirera. 2006. Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood. Lung Cancer 51, 143-158. https://doi.org/10.1016/j.lungcan.2005.09.005
  3. Cho, H. J., Y. J. Jeong, K. K. Park, Y. Y. Park, I. K. Chung, K. G. Lee, J. H. Yeo, S. M. Han, Y. S. Bae, and Y. C. Chang. 2010. Bee venom suppresses PMA-mediated MMP-9 gene activation via JNK/p38 and NF-kappaB-dependent mechanisms. J. Ethnopharmacol. 127, 662-668. https://doi.org/10.1016/j.jep.2009.12.007
  4. Chu, S. T., H. H. Cheng, C. J. Huang, H. C. Chang, C. C. Chi, H. H. Su, S. S. Hsu, J. L. Wang, I. S. Chen, S. I. Liu, Y. C. Lu, J. K. Huang, C. M. Ho, and C. R. Jan. 2007. Phospholipase A2-independent $Ca^{2+}$ entry and subsequent apoptosis induced by melittin in human MG63 osteosarcoma cells. Life Sci. 80, 364-369. https://doi.org/10.1016/j.lfs.2006.09.024
  5. Cristofanilli, M., C. Charnsangavej, and G. N. Hortobagyi. 2002. Angiogenesis modulation in cancer research: novel clinical approaches. Nat. Rev. Drug Discov. 1, 415-426. https://doi.org/10.1038/nrd819
  6. Dery, M. A., M. D. Michaud, and D. E. Richard. 2005. Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators. Int. J. Biochem Cell Biol. 37, 535-540. https://doi.org/10.1016/j.biocel.2004.08.012
  7. Fox, S. B., K. C. Gatter, and A. L. Harris. 1996. Tumour angiogenesis. J. Pathol. 179, 232-237. https://doi.org/10.1002/(SICI)1096-9896(199607)179:3<232::AID-PATH505>3.0.CO;2-A
  8. Giles, F. J., W. T. Bellamy, Z. Estrov, S. M. O'Brien, S. Verstovsek, F. Ravandi, M. Beran, P. Bycott, Y. Pithavala, H. Steinfeldt, S. D. Reich, A. F. List, and K. W. Yee. 2006. The anti-angiogenesis agent, AG-013736, has minimal activity in elderly patients with poor prognosis acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). Leuk. Res. 30, 801-811. https://doi.org/10.1016/j.leukres.2005.10.024
  9. Gorlach, A., I. Diebold, V. B. Schini-Kerth, U. Berchner- Pfannschmidt, U. Roth, R. P. Brandes, T. Kietzmann, and R. Busse. 2001. Thrombin activates the hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells: Role of the p22 (phox)-containing NADPH oxidase. Circ. Res. 89, 47-54. https://doi.org/10.1161/hh1301.092678
  10. Hanahan, D. and J. Folkman. 1996. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353-364. https://doi.org/10.1016/S0092-8674(00)80108-7
  11. Hao, J., M. G. Liu, Y. Q. Yu, F. L. Cao, Z. Li, Z. M. Lu, and J. Chen. 2008. Roles of peripheral mitogen-activated protein kinases in melittin-induced nociception and hyperalgesia. Neuroscience 152, 1067-1075. https://doi.org/10.1016/j.neuroscience.2007.12.038
  12. Hon, W. C., M. I. Wilson, K. Harlos, T. D. Claridge, C. J. Schofield, C. W. Pugh, P. H. Maxwell, P. J. Ratcliffe, D. I. Stuart, and E. Y. Jones. 2002. Structural basis for the recognition of hydroxyproline in HIF-1 alpha by pVHL. Nature 417, 975-978. https://doi.org/10.1038/nature00767
  13. Hon, W. C., M. I. Wilson, K. Harlos, T. D. Claridge, C. J. Schofield, C. W. Pugh, P. H. Maxwell, P. J. Ratcliffe, D. I. Stuart, and E. Y. Jones. 2002. Structural basis for the recognition of hydroxyproline in HIF-1 alpha by pVHL. Nature 417, 975-978. https://doi.org/10.1038/nature00767
  14. Ivan, M., K. Kondo, H. Yang, W. Kim, J. Valiando, M. Ohh, A. Salic, J. M. Asara, W. S. Lane, and W. G. Kaelin, Jr. 2001. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 292, 464-468. https://doi.org/10.1126/science.1059817
  15. Jang, M. H., M. C. Shin, S. Lim, S. M. Han, H. J. Park, I. Shin, J. S. Lee, K. A. Kim, E. H. Kim, and C. J. Kim. 2003. Bee venom induces apoptosis and inhibits expression of cyclooxygenase-2 mRNA in human lung cancer cell line NCI-H1299. J. Pharmacol Sci. 91, 95-104. https://doi.org/10.1254/jphs.91.95
  16. Jeon, S., N. H. Kim, B. S. Koo, H. J. Lee, and A. Y. Lee. 2007. Bee venom stimulates human melanocyte proliferation, melanogenesis, dendricity and migration. Exp. Mol. Med. 39, 603-613. https://doi.org/10.1038/emm.2007.66
  17. Jiang, B. H., G. Jiang, J. Z. Zheng, Z. Lu, T. Hunter, and P. K. Vogt. 2001. Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1. Cell Growth Differ. 12, 363-369.
  18. Leung, D. W., G. Cachianes, W. J. Kuang, D. V. Goeddel, and N. Ferrara. 1989. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246, 1306-1309. https://doi.org/10.1126/science.2479986
  19. Lin, C. W., W. C. Hou, S. C. Shen, S. H. Juan, C. H. Ko, L. M. Wang, and Y. C. Chen. 2008. Quercetin inhibition of tumor invasion via suppressing PKC delta/ERK/AP-1- dependent matrix metalloproteinase-9 activation in breast carcinoma cells. Carcinogenesis 29, 1807-1815. https://doi.org/10.1093/carcin/bgn162
  20. Masson, N., C. Willam, P. H. Maxwell, C. W. Pugh, and P. J. Ratcliffe. 2001. Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation. EMBO. J. 20, 5197-5206. https://doi.org/10.1093/emboj/20.18.5197
  21. Maxwell, P. and K. Salnikow. 2004. HIF-1: an oxygen and metal responsive transcription factor. Cancer Biol. Ther. 3, 29-35. https://doi.org/10.4161/cbt.3.1.547
  22. Moon, D. O., S. Y. Park, Y. H. Choi, N. D. Kim, C. Lee, and G. Y. Kim. 2008. Melittin induces Bcl-2 and caspase-3-dependent apoptosis through downregulation of Akt phosphorylation in human leukemic U937 cells. Toxicon. 51, 112-120. https://doi.org/10.1016/j.toxicon.2007.08.015
  23. Moon, D. O., S. Y. Park, M. S. Heo, K. C. Kim, C. Park, W. S. Ko, Y. H. Choi, and G. Y. Kim. 2006. Key regulators in bee venom-induced apoptosis are Bcl-2 and caspase-3 in human leukemic U937 cells through downregulation of ERK and Akt. Int. Immunopharmacol. 6, 1796-1807. https://doi.org/10.1016/j.intimp.2006.07.027
  24. Moyrand, F., T. Fontaine, and G. Janbon. 2007. Systematic capsule gene disruption reveals the central role of galactose metabolism on Cryptococcus neoformans virulence. Mol. Microbiol. 64, 771-781. https://doi.org/10.1111/j.1365-2958.2007.05695.x
  25. Park, M. H., M. S. Choi, D. H. Kwak, K. W. Oh, D. Y. Yoon, S. B. Han, H. S. Song, M. J. Song, and J. T. Hong. 2010. Anti-cancer effect of bee venom in prostate cancer cells through activation of caspase pathway via inactivation of NF-kappaB. Prostate [Epub ahead of print].
  26. Patra, S. K. 2008. Dissecting lipid raft facilitated cell signaling pathways in cancer. Biochim Biophys Acta. 1785, 182-206.
  27. Raspollini, M. R., F. Castiglione, F. Garbini, A. Villanucci, G. Amunni, G. Baroni, V. Boddi, and G. L. Taddei. 2005. Correlation of epidermal growth factor receptor expression with tumor microdensity vessels and with vascular endothelial growth factor expression in ovarian carcinoma. Int. J. Surg Pathol. 13, 135-142. https://doi.org/10.1177/106689690501300202
  28. Richard, D. E., E. Berra, and J. Pouyssegur. 2000. Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells. J. Biol. Chem. 275, 26765-26771.
  29. Salnikow, K., W. G. An, G. Melillo, M. V. Blagosklonny, and M. Costa. 1999. Nickel-induced transformation shifts the balance between HIF-1 and p53 transcription factors. Carcinogenesis 20, 1819-1823. https://doi.org/10.1093/carcin/20.9.1819
  30. Salnikow, K., M. V. Blagosklonny, H. Ryan, R. Johnson, and M. Costa. 2000. Carcinogenic nickel induces genes involved with hypoxic stress. Cancer Res. 60, 38-41.
  31. Shi, Y. H., Y. X. Wang, L. Bingle, L. H. Gong, W. J. Heng, Y. Li, and W. G. Fang. 2005. In vitro study of HIF-1 activation and VEGF release by bFGF in the T47D breast cancer cell line under normoxic conditions: involvement of PI-3K/Akt and MEK1/ERK pathways. J. Pathol. 205, 530-536. https://doi.org/10.1002/path.1734
  32. Son, D. J., S. J. Ha, H. S. Song, Y. Lim, Y. P. Yun, J. W. Lee, D. C. Moon, Y. H. Park, B. S. Park, M. J. Song, and J. T. Hong. 2006. Melittin inhibits vascular smooth muscle cell proliferation through induction of apoptosis via suppression of nuclear factor-kappaB and Akt activation and enhancement of apoptotic protein expression. J. Pharmacol. Exp. Ther. 317, 627-634. https://doi.org/10.1124/jpet.105.095901
  33. Son, D. J., J. W. Lee, Y. H. Lee, H. S. Song, C. K. Lee, and J. T. Hong. 2007. Therapeutic application of anti-arthritis, pain-releasing, and anti-cancer effects of bee venom and its constituent compounds. Pharmacol Ther. 115, 246-270. https://doi.org/10.1016/j.pharmthera.2007.04.004
  34. Song, C. C., X. Lu, B. B. Cheng, J. Du, B. Li, and C. Q. Ling. 2007. Effects of melittin on growth and angiogenesis of human hepatocellular carcinoma BEL-7402 cell xenografts in nude mice. Ai Zheng. 26, 1315-1322.
  35. Wang, C., T. Chen, N. Zhang, M. Yang, B. Li, X. Lu, X. Cao, and C. Ling. 2009. Melittin, a major component of bee venom, sensitizes human hepatocellular carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by activating CaMKII-TAK1- JNK/p38 and inhibiting IkappaBalpha kinase-NFkappaB. J. Biol. Chem. 284, 3804-3813. https://doi.org/10.1074/jbc.M807191200
  36. Wang, G. L. and G. L. Semenza. 1993. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc. Natl. Acad Sci USA 90, 4304-4308. https://doi.org/10.1073/pnas.90.9.4304
  37. Wang, G. L. and G. L. Semenza. 1995. Purification and characterization of hypoxia-inducible factor 1. J. Biol. Chem. 270, 1230-1237. https://doi.org/10.1074/jbc.270.3.1230
  38. Zhong, H., K. Chiles, D. Feldser, E. Laughner, C. Hanrahan, M. M. Georgescu, J. W. Simons, and G. L. Semenza. 2000. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res. 60, 1541-1545.

피인용 문헌

  1. Bee Venom Exerts Neuroprotective Effects on Neuronal Cells and Astrocytes under Hypoxic Conditions Through MAPK Signaling Pathways vol.23, pp.1, 2016, https://doi.org/10.5385/nm.2016.23.1.43